Effect of the Ratio of Betamethasone to TNF-α siRNA Coencapsulated in Solid Lipid Nanoparticles on the Acute Proinflammatory Activity of the Nanoparticles
- 17 September 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 16 (11) , 4496-4506
Abstract
There is evidence that encapsulating glucocorticoids into nucleic acid-containing nanoparticles reduces the inflammatory toxicities of the nanoparticles. Herein, using betamethasone acetate (BA), a glucocorticoid, and a solid lipid nanoparticle formulation of siRNA, we confirmed that co-encapsulating BA into the siRNA solid lipid nanoparticles significantly reduced the proinflammatory activity of the siRNA nanoparticles in a mouse model. Using TNF-α siRNA, we then showed that the BA and TNF-α siRNA co-encapsulated into the solid lipid nanoparticles acted as a dual anti-inflammatory and synergistically reduced TNF-α release by mouse macrophages in culture following stimulation with lipopolysaccharide, as compared to solid lipid nanoparticles encapsulated with TNF-α siRNA or BA alone. Importantly, upon studying the effect of the ratio of BA and TNF-α siRNA on the proinflammatory activity of the resultant nanoparticles, we identified that BA and TNF-α siRNA co-encapsulated solid lipid nanoparticles prepared with a BA to TNF-α siRNA weight ratio of 2:1 induced the lowest proinflammatory cytokine production by macrophages in culture. This result was in comparison to nanoparticles prepared with BA to TNFα siRNA ratios both higher and lower than 2:1 (i.e. 4:1, 1:1, and 0.5:1), and is likely due to differences in molecular interactions among the various components in the BA and TNF-α-siRNA co-encapsulated solid lipid nanoparticles at these ratios. Encapsulating glucocorticoids into siRNA-nanoparticles represents a viable strategy to reduce the proinflammatory activity of the nanoparticles; however, the ratio of the glucocorticoid to siRNA in the nanoparticles requires optimization.Keywords
Funding Information
- King Saud University
- University of Texas at Austin
- National Institutes of Health (R43AR074360)
This publication has 25 references indexed in Scilit:
- Intracellular delivery of oligonucleotides in Helicobacter pylori by fusogenic liposomes in the presence of gastric mucusBiomaterials, 2017
- The effect of dexamethasone/cell-penetrating peptide nanoparticles on gene delivery for inner ear therapyInternational Journal of Nanomedicine, 2016
- Multifunctional Cationic Lipid-Based Nanoparticles Facilitate Endosomal Escape and Reduction-Triggered Cytosolic siRNA ReleaseMolecular Pharmaceutics, 2014
- Lysosomal Delivery of a Lipophilic Gemcitabine Prodrug Using Novel Acid-Sensitive Micelles Improved Its Antitumor ActivityBioconjugate Chemistry, 2012
- Genomic and nongenomic effects of glucocorticoidsNature Clinical Practice Rheumatology, 2008
- RNAi Mechanisms and ApplicationsBioTechniques, 2008
- Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering☆Advanced Drug Delivery Reviews, 2007
- Induction of Inflammatory Cytokines and Interferon Responses by Double-stranded and Single-stranded siRNAs is Sequence-dependent and Requires Endosomal LocalizationJournal of Molecular Biology, 2005
- Cationic lipids enhance siRNA-mediated interferon response in miceBiochemical and Biophysical Research Communications, 2005
- Interconversion Studies of Betamethasone Acetate PolymorphsDrug Development and Industrial Pharmacy, 2005